Literature DB >> 2918858

Enhanced transmembrane signalling activity of monoclonal antibody heteroconjugates suggests molecular interactions between receptors on the T cell surface.

J A Ledbetter1, N A Norris, A Grossmann, L S Grosmaire, C H June, F M Uckun, W L Cosand, P S Rabinovitch.   

Abstract

Signal transduction occurs through multiple receptors expressed on mature, resting T cells. In addition to the CD3-T cell receptor complex, the CD2, CD4, CD5, CD7, CD8 and CD28 receptors mobilize cytoplasmic calcium within minutes of binding with monoclonal antibodies and additional crosslinking occurs on the cell surface. As an approach to study the interactions between these receptors and their transduced signals, monoclonal antibodies to each of these receptors were covalently coupled as heteroconjugates and investigated for activity in cytoplasmic calcium mobilization using indo-1 and flow cytometry. Of a total of 35 conjugates studied, there were seven heteroconjugates that showed an increase in activity and these consisted of either certain conjugates of anti-CD3 or certain conjugates of anti-CD5. The CD3-CD2, CD3-CD4, CD3-CD6 and CD3-CD8 heteroconjugates each gained two to three orders of magnitude in titer in calcium mobilization compared to unconjugated CD3 or the CD3-CD3 conjugate. The increase in activity was not accompanied by an increase in binding titer, indicating that signal transduction occurred at lower levels of receptor occupancy. The increased activity was dependent in each case on the relevant second receptor, since unconjugated CD2, CD4, CD6 or CD8 MAb could block the activity of the corresponding heteroconjugate. Neither CD3-CD5, CD3-CD28 or CD3-CD3 conjugates gained activity, whereas CD3-CD7 heteroconjugates gained slightly in activity. The heteroconjugates with CD5 that acquired ability to mobilize calcium at low concns (less than 5 micrograms/ml) were CD5-CD4, CD5-CD8 and CD5-CD6. Their activity could be inhibited by either CD5 MAb or the second MAb of the heteroconjugate. The increased activity of CD3 or CD5 heteroconjugates was observed in the absence of extracellular calcium. Size exclusion chromatography of heteroconjugates demonstrated that 1:1 ratios were optimal, but larger conjugates were also active. These results suggest that certain receptors are capable for molecular interactions on the cell surface to form complexes with enhanced activity in signal transduction leading to calcium mobilization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918858     DOI: 10.1016/0161-5890(89)90095-3

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 2.  Molecular analysis of protein interactions mediating the function of the cell surface protein CD8.

Authors:  L Devine; P B Kavathas
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.

Authors:  M A Bowen; D D Patel; X Li; B Modrell; A R Malacko; W C Wang; H Marquardt; M Neubauer; J M Pesando; U Francke
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

4.  Itk negatively regulates induction of T cell proliferation by CD28 costimulation.

Authors:  X C Liao; S Fournier; N Killeen; A Weiss; J P Allison; D R Littman
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

5.  Association of CD8 with p56lck is required for early T cell signalling events.

Authors:  N J Chalupny; J A Ledbetter; P Kavathas
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

6.  Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors.

Authors:  S Wee; G L Schieven; J M Kirihara; T T Tsu; J A Ledbetter; A Aruffo
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

7.  Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.

Authors:  D D Patel; S F Wee; L P Whichard; M A Bowen; J M Pesando; A Aruffo; B F Haynes
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.